PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.
PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:
- Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
- Assessment of regulatory needs (ARN).
- Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, recommendations for inclusion in the Authorisation List, restriction.
A summary of all the substance-specific activities can be found under ‘Details’ for each entry.
Further information
- Understanding PACT
- Integrated Regulatory Strategy
- Substances of potential concern
- Dossier Evaluation status
- Substance evaluation
- Endocrine disruptor assessment
- PBT assessment
- Assessment of regulatory needs list
- Registry of CLH intentions until outcome
- Registry of SVHC intentions until outcome
- Recommendations for inclusion in the Authorisation list
- Registry of restriction intentions until outcome
Filter the list
The List does not contain any Substances.
| Data generation and assessment | ARN | Regulatory risk management | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Methyl methacrylate | 201-297-1 | 80-62-6 | 1 | - | 2 | - | 1 | 1 | - | - | - | Details |
| 1,1,3,3-tetramethylguanidine | 201-302-7 | 80-70-6 | - | - | - | - | 1 | - | - | - | - | Details |
| 1,3-dimethylimidazolidin-2-one | 201-304-8 | 80-73-9 | - | - | 3 | - | - | 1 | - | - | - | Details |
| Terpineol | 232-268-1 | 8000-41-7 | - | - | - | - | - | 1 | - | - | - | Details |
| Toxaphene | 232-283-3 | 8001-35-2 | - | - | - | - | - | - | - | - | - | Details |
| Castor oil, hydrogenated | 232-292-2 | 8001-78-3 | - | - | 2 | - | 1 | - | - | - | - | Details |
|
Castor oil
Extractives and their physically modified derivatives. It consists primarily of the glycerides of the fatty acid ricinoleic. (Ricinus communis, Euphorbiaceae).
|
232-293-8 | 8001-79-4 | - | - | - | - | 1 | - | - | - | - | Details |
| Sodium 1-amino-4-[[3,5-bis[[(chloroacetyl)amino]methyl]-2,4,6-trimethylphenyl]amino]-9,10-dihydro-9,10-dioxoanthracene-2-sulphonate | 279-365-5 | 80010-51-1 | - | - | 1 | - | - | - | - | - | - | Details |
|
Rape oil
Extractives and their physically modified derivatives. It consists primarily of the glycerides of the fatty acids erucic, linoleic and oleic. (Brassica napus, Cruciferae).
|
232-299-0 | 8002-13-9 | - | - | - | - | - | 1 | - | - | - | Details |
|
Tall oil
A complex combination of tall oil rosin and fatty acids derived from acidulation of crude tall oil soap and including that which is further refined. Contains at least 10% rosin.
|
232-304-6 | 8002-26-4 | - | - | 2 | - | - | - | - | - | - | Details |